Mast cells within cellular networks - 03/10/19
Abstract |
Mast cells are highly versatile in terms of their mode of activation by a host of stimuli and their ability to flexibly release a plethora of biologically highly active mediators. Within the immune system, mast cells can best be designated as an active nexus interlinking innate and adaptive immunity. Here we try to draw an arc from initiation of acute inflammatory reactions to microbial pathogens to development of adaptive immunity and allergies. This multifaceted nature of mast cells is made possible by interaction with multiple cell types of immunologic and nonimmunologic origin. Examples for the former include neutrophils, eosinophils, T cells, and professional antigen-presenting cells. These interactions allow mast cells to orchestrate inflammatory innate reactions and complex adaptive immunity, including the pathogenesis of allergies. Important partners of nonimmunologic origin include cells of the sensory neuronal system. The intimate association between mast cells and sensory nerve fibers allows bidirectional communication, leading to neurogenic inflammation. Evidence is accumulating that this mast cell/nerve crosstalk is of pathophysiologic relevance in patients with allergic diseases, such as asthma.
Le texte complet de cet article est disponible en PDF.Key words : Mast cells, neutrophils, eosinophils, T cells, asthma, murine cytomegalovirus infection, vaccination, substance P, sensory nerves, neurogenic inflammation
Abbreviations used : APC, CGRP, mCMV, MCTC, MHCII, MRGPRX2, NGF, NK1R, SP, TLR, TRPV1
Plan
This article was published as part of a supplement sponsored by the members of the Priority Programme of the Deutsche Forschungsgemeinschaft (DFG) SPP 1394: Mast cells - promoters of health and modulators of disease. |
|
Part of the work reported here was funded by the Deutsche Forschungsgemeinschaft, Priority Programme SPP1394, individual projects STA 984/4-1 (to M.S.) and BR 212/3-1 (to A.B.). |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 144 - N° 4S
P. S46-S54 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?